Research Article

Portraying Persons Who Inject Drugs Recently Infected with Hepatitis C Accessing Antiviral Treatment: A Cluster Analysis

Table 2

Participants typology (cluster analysis; ).

Class 1

(23.3%)
Class 2

(25.0%)
Class 3

(18.3%)
Class 4

(33.3%)
Combined

(100.0%)

Predisposing factors
 Age categories (%)
  <30 years old11 (78.6)13 (86.7)4 (36.4)0 (0.0)28 (46.7)
  30–39  years old3 (21.4)2 (13.3)7 (63.6)3 (15.0)15 (25.0)
  40  years old and over0 (0.0)0 (0.0)0 (0.0)17 (85.0)17 (28.3)
 Gender (%)
  Females12 (85.7)0 (0.0)0 (0.0)3 (15.0)15 (25.0)
  Males2 (14.3)15 (100.0)11 (100.0)17 (85.0)45 (75.0)
 Education (%)
  Elementary/secondary13 (92.9)12 (80.0)6 (54.5)13 (65.0)44 (73.3)
  College or over1 (7.1)3 (20.0)5 (45.5)7 (35.0)16 (26.7)
Enabling factor
 Housing (%)
  Stable housing (home, apartment, room)9 (64.3)9 (60.0)5 (45.5)2 (10.0)25 (41.7)
  Temporary housing (therapy, prison, shelter)4 (28.6)2 (13.3)0 (0.0)16 (80.0)22 (36.7)
  Homeless1 (7.1)4 (26.7)6 (54.5)2 (10.0)13 (21.7)
Need factors
 IV cocaine consumption (%)9 (64.3)15 (100.0)11 (100.0)18 (90.0)53 (88.3)
 IV heroine consumption (%)9 (64.3)15 (100.0)2 (18.2)3 (15.0)29 (48.3)
 Alcohol consumption (%)8 (57.1)13 (86.7)4 (36.4)11 (55.0)36 (60.0)
 Quality of life (SF-36) (mean (SD)
  PCS mean (SD)45.7 (6.9)46.4 (9.4)46.7 (9.1)46.8 (13.4)46.4 (10.2)
  MCS mean (SD)25.3 (12.1)37.0 (14.8)37.5 (8.1)35.7 (15.3)33.9 (13.9)
Health service utilization
 Methadone program (%)5 (35.7)8 (53.3)3 (27.3)4 (20.0)20 (33.3)
 Hepatitis B vaccine (%)4 (28.6)3 (20.0)0 (0.0)10 (50.0)17 (28.3)
 Followed up by a family physician (%) 5 (35.7)1 (6.7)0 (0.0)5 (25.0)11 (18.3)
 Having initiated treatment    (%)2 (14.3)8 (53.3)0 (0.0)11 (55.0)21 (35.0)